KARD
Kardigan, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.94
−0.69%Sep 30, 2026, 12:06 UTC
Kristin Reinke was appointed as a Class I Director and Chair of the Audit Committee of Kardigan, Inc., effective September 29, 2026.
Sep 30, 2026, 12:06 UTC
Doug Giordano departed as a director and member of the Audit Committee of Kardigan, Inc., effective September 29, 2026.
Aug 11, 2026, 11:00 UTC
Kardigan, Inc. reported its financial results for the second quarter ended June 30, 2026.
Source:Jun 22, 2026, 21:03 UTC
Kardigan closed its initial public offering of 28,750,000 shares of common stock at $16.00 per share, raising $460 million in gross proceeds.
Source:Jun 18, 2026, 00:39 UTC
Kardigan Inc. raised $400 million in an upsized US initial public offering that priced at the top of its marketed range.
Source:Jun 11, 2026, 10:40 UTC
Kardigan, a heart health biotech company, is seeking $373.3 million in its US initial public offering.
Source: